| Autor: |
Andrew V, Mossine, Sean S, Tanzey, Allen F, Brooks, Katarina J, Makaravage, Naoko, Ichiishi, Jason M, Miller, Bradford D, Henderson, Thomas, Erhard, Christian, Bruetting, Marc B, Skaddan, Melanie S, Sanford, Peter J H, Scott |
| Rok vydání: |
2019 |
| Předmět: |
|
| Zdroj: |
Nat Protoc |
| ISSN: |
1750-2799 |
| Popis: |
[(18)F]6-Fluoro-L-DOPA ([(18)F]FDOPA), is used for diagnostic PET imaging. Using this protocol, radiofluorination of the electron-rich catechol ring can be achieved in the presence of the amino acid group by Cu-mediated fluorination of a pinacol boronate precursor. [(18)F]6-Fluoro-L-DOPA ([(18)F]FDOPA) is a diagnostic radiopharmaceutical for positron emission tomography (PET) imaging that is used to image Parkinson’s disease, brain tumors, and focal hyperinsulinism of infancy. Despite these important applications, [(18)F]FDOPA PET remains underutilized because of synthetic challenges associated with accessing the radiotracer for clinical use, stemming from the need to radiofluorinate a highly electron rich catechol ring in the presence of an amino acid. To address this longstanding challenge in the PET radiochemistry community, we have developed a one-pot, two-step synthesis of high molar activity [(18)F]FDOPA by Cu-mediated fluorination of a pinacol boronate (BPin) precursor. The method is fully automated, has been validated to work well at two separate sites (an academic facility with a cyclotron on site and an industry lab purchasing [(18)F]fluoride from an outside vendor), and provides [(18)F]FDOPA in reasonable radiochemical yield (2.44 ± 0.70 GBq, 66 ± 19 mCi, 5 ± 1%), excellent radiochemical purity (>98%) and high molar activity (76 ± 30 TBq/mmol, 2050 ± 804 Ci/mmol), n=26. Herein we report a detailed protocol for the synthesis of [(18)F]FDOPA which has been successfully implemented at two sites and validated for production of the radiotracer for human use. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink